ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CARA Cara Therapeutics Inc

0.8999
0.0218 (2.48%)
Mar 18 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cara Therapeutics Inc CARA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0218 2.48% 0.8999 19:19:32
Open Price Low Price High Price Close Price Prev Close
0.8713 0.8006 0.9297 0.9074 0.8781
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
3/07/202407:00GLOBECara Therapeutics to Host Notalgia Paresthetica (NP) Virtual..
3/06/202416:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/04/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:10EDGAR2Form 8-K - Current report
3/04/202416:01GLOBECara Therapeutics Announces Fourth Quarter and Full Year..
2/13/202418:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202417:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202417:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202417:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202417:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/12/202416:01GLOBECara Therapeutics to Announce Fourth Quarter and Full Year..
2/05/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/05/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202416:59EDGAR2Form 8-K - Current report
1/29/202415:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/22/202416:19EDGAR2Form 8-K - Current report
1/22/202407:00GLOBECara Therapeutics Prioritizes Late-Stage Notalgia..
12/18/202307:10EDGAR2Form 8-K - Current report
12/18/202307:00GLOBECara Therapeutics Announces Outcome from Dose-Finding Part A..
11/13/202316:28EDGAR2Form 8-K - Current report
11/13/202316:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:11EDGAR2Form 8-K - Current report
11/13/202316:01GLOBECara Therapeutics Reports Third Quarter 2023 Financial..
11/03/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202307:10EDGAR2Form 8-K - Current report
11/02/202307:00GLOBECara Therapeutics Announces up to $40.0 Million Non-Dilutive..
10/23/202307:00GLOBECara Therapeutics to Announce Third Quarter 2023 Financial..
9/25/202307:00GLOBECara Therapeutics Announces Approval of KORSUVA® IV..
9/05/202307:00GLOBECara Therapeutics to Present at the H.C. Wainwright 25th..
8/07/202316:24EDGAR2Form 8-K - Current report
8/07/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:10EDGAR2Form 8-K - Current report
8/07/202316:01GLOBECara Therapeutics Reports Second Quarter 2023 Financial..
8/04/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/04/202317:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/03/202307:06EDGAR2Form 8-K - Current report
8/03/202307:00GLOBECara Therapeutics Appoints Helen M. Boudreau to Board of..
8/02/202307:00GLOBECara Therapeutics to Present at the Canaccord Genuity 43rd..
7/25/202316:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
7/24/202307:00GLOBECara Therapeutics to Announce Second Quarter 2023 Financial..
6/02/202318:46PRNUSPalo Alto Networks Set to S&P 500; Others to Join S&P MidCap..
6/01/202307:00GLOBECara Therapeutics to Present at the Jefferies Healthcare..
5/18/202302:00GLOBEKapruvia® (difelikefalin) recommended by England’s NICE for..
5/15/202316:01GLOBECara Therapeutics Reports First Quarter 2023 Financial..
5/01/202307:00GLOBECara Therapeutics to Announce First Quarter 2023 Financial..

Your Recent History

Delayed Upgrade Clock